NO911041L - Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika. - Google Patents

Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika.

Info

Publication number
NO911041L
NO911041L NO91911041A NO911041A NO911041L NO 911041 L NO911041 L NO 911041L NO 91911041 A NO91911041 A NO 91911041A NO 911041 A NO911041 A NO 911041A NO 911041 L NO911041 L NO 911041L
Authority
NO
Norway
Prior art keywords
preparation
tetrazolyltyomethyl
procedure
cephalosporin antibiotics
cephalosporin
Prior art date
Application number
NO91911041A
Other languages
English (en)
Other versions
NO911041D0 (no
Inventor
Frederick Henri Jung
Original Assignee
Ici Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Pharma filed Critical Ici Pharma
Publication of NO911041D0 publication Critical patent/NO911041D0/no
Publication of NO911041L publication Critical patent/NO911041L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)

Abstract

Det beskrives en forbindelse med formel (II):. og farmasøytisk akseptable' salter og in vivo hydrolyserbare estere derav, samt fremgangsmåter'for fremstilling av disse og deres anvendelse som antibakterielle midler.
NO91911041A 1990-03-16 1991-03-15 Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika. NO911041L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90400724 1990-03-16

Publications (2)

Publication Number Publication Date
NO911041D0 NO911041D0 (no) 1991-03-15
NO911041L true NO911041L (no) 1991-09-17

Family

ID=8205690

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911041A NO911041L (no) 1990-03-16 1991-03-15 Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika.

Country Status (16)

Country Link
US (1) US5200404A (no)
EP (1) EP0447118B1 (no)
JP (1) JPH05247058A (no)
KR (1) KR910016762A (no)
AT (1) ATE131484T1 (no)
AU (1) AU638556B2 (no)
CA (1) CA2038411A1 (no)
DE (1) DE69115313T2 (no)
FI (1) FI911286A (no)
GB (1) GB9104238D0 (no)
IE (1) IE910711A1 (no)
IL (1) IL97439A0 (no)
NO (1) NO911041L (no)
NZ (1) NZ237351A (no)
PT (1) PT97044A (no)
ZA (1) ZA911657B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0544166A3 (en) * 1991-11-26 1993-11-03 Hoffmann La Roche Cephalosporinderivatives
JPH11124384A (ja) * 1997-10-17 1999-05-11 Otsuka Chem Co Ltd ３−セフェム化合物の製造法
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
TWI417095B (zh) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc １，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
PT2200985E (pt) 2007-09-14 2011-07-21 Ortho Mcneil Janssen Pharm 4-(aril-x-fenil)-1h-piridin-2-onas 1,3-dissubstituídas
UA100126C2 (en) 2007-09-14 2012-11-26 Аддекс Фарма С.А. 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1, 4'] bipyridinyl-2'-ones
AU2009289784B2 (en) 2008-09-02 2012-03-22 Addex Pharma S.A. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
BRPI0921333A2 (pt) 2008-11-28 2015-12-29 Addex Pharmaceuticals Sa derivados de indol e benzoxazina como moduladores de receptores de glutamato metabotrópicos
BRPI1010831A2 (pt) 2009-05-12 2016-04-05 Addex Pharmaceuticals Sa derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
KR101753826B1 (ko) 2009-05-12 2017-07-04 얀센 파마슈티칼즈, 인코포레이티드 1,２,４―트리아졸로［４,３―ａ］피리딘 유도체 및 신경정신 질환의 치료 또는 예방을 위한 이들의 용도
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
ES2536433T3 (es) 2010-11-08 2015-05-25 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
EP2649069B1 (en) 2010-11-08 2015-08-26 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
MX2016009471A (es) 2014-01-21 2016-10-13 Janssen Pharmaceutica Nv Combinaciones que comprenden agonistas ortostericos o moduladores alostericos positivos del receptor glutamatergico metabotropico de subtipo 2 y su uso.
HUE045610T2 (hu) 2014-01-21 2020-01-28 Janssen Pharmaceutica Nv 2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait vagy ortosztérikus agonistáit tartalmazó kombinációk és alkalmazásuk

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3926957A (en) * 1971-01-29 1975-12-16 Glaxo Lab Ltd Penicillin antibiotics
GB1433141A (en) * 1972-07-07 1976-04-22 Glaxo Lab Ltd Antibiotics
US4024134A (en) * 1971-01-29 1977-05-17 Glaxo Laboratories Limited Syn isomers of cephalosporins having α-hydroximino- or α-acyloxyiminoacylamido groups at position-7
US3991046A (en) * 1972-07-07 1976-11-09 Glaxo Laboratories Limited Penicillin antibiotics
US4493833A (en) * 1976-04-12 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds
DE2716677C2 (de) * 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
AU536842B2 (en) * 1978-12-29 1984-05-24 Fujisawa Pharmaceutical Co., Ltd. Cephalosporin antibiotics
EP0272827A3 (en) * 1986-12-23 1990-02-07 ZENECA Pharma S.A. 3-heterocyclicthiomethyl cephalosphorins

Also Published As

Publication number Publication date
EP0447118A3 (en) 1992-06-03
US5200404A (en) 1993-04-06
EP0447118A2 (en) 1991-09-18
FI911286A0 (fi) 1991-03-15
KR910016762A (ko) 1991-11-05
JPH05247058A (ja) 1993-09-24
ATE131484T1 (de) 1995-12-15
IL97439A0 (en) 1992-06-21
PT97044A (pt) 1991-10-31
AU7263991A (en) 1991-09-19
DE69115313D1 (de) 1996-01-25
NO911041D0 (no) 1991-03-15
EP0447118B1 (en) 1995-12-13
DE69115313T2 (de) 1996-05-02
CA2038411A1 (en) 1991-09-17
AU638556B2 (en) 1993-07-01
IE910711A1 (en) 1991-09-25
ZA911657B (en) 1991-11-27
NZ237351A (en) 1992-12-23
GB9104238D0 (en) 1991-04-17
FI911286A (fi) 1991-09-17

Similar Documents

Publication Publication Date Title
NO911041D0 (no) Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika.
AU6889294A (en) Novel intermediates useful in the preparation of heteroaroyl derivatives of monocyclic beta-lactam antibiotics
ATE170861T1 (de) Antibiotische carbapenemderivate
EP0471388A3 (de) Mittel zur Behandlung der Herzinsuffizienz
SE8601963D0 (sv) O-sulfated beta-lactam hydroxamic acids
SE7707366L (sv) Forfarande for framstellning av 7alfa-metoxi-cefalosporansyraderivat
NO890287D0 (no) Fremstilling av beta-laktam-antibiotika.
DE69429447D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
AU560185B2 (en) Penicillin derivatives
JO1229B1 (en) Penicillin derivatives